Literature DB >> 28362411

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload.

Bérengère Koehl1, Florence Missud2, Laurent Holvoet2, Ghislaine Ithier2, Oliver Sakalian-Black3, Zinedine Haouari2, Emmanuelle Lesprit4, André Baruchel5, Malika Benkerrou2.   

Abstract

Children with sickle cell anemia (SCA) may be at risk of cerebral vasculopathy and strokes, which can be prevented by chronic transfusion programs. Repeated transfusions of packed red blood cells (PRBCs) is currently the simplest and most used technique for chronic transfusion programs. However, iron overload is one of the major side effects of this therapy. More developed methods exist, notably the apheresis of RBC (erythrapheresis), which is currently the safest and most efficient method. However, it is costly, complicated, and cannot be implemented everywhere, nor is it suitable for all patients. Manual exchange transfusions combine one or more manual phlebotomies with a PRBC transfusion. At the Reference Center of Sickle Cell Disease, we set up a continuous method of manual exchange transfusion that is feasible for all hospital settings, demands no specific equipment, and is widely applicable. In terms of HbS decrease, stroke prevention, and iron overload prevention, this method showed comparable efficiency to erythrapheresis. In cases where erythrapheresis is not available, this method can be a good alternative for patients and care centers.

Entities:  

Mesh:

Year:  2017        PMID: 28362411      PMCID: PMC5408855          DOI: 10.3791/55172

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

Review 1.  Sickle-cell disease.

Authors:  Marie J Stuart; Ronald L Nagel
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

2.  Cerebrovascular accidents in sickle cell disease: rates and risk factors.

Authors:  K Ohene-Frempong; S J Weiner; L A Sleeper; S T Miller; S Embury; J W Moohr; D L Wethers; C H Pegelow; F M Gill
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

3.  Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.

Authors:  Douglas J Scothorn; Cynthia Price; Daniel Schwartz; Cindy Terrill; George R Buchanan; Wanda Shurney; Ingrid Sarniak; Robert Fallon; Jen-Yih Chu; Charles H Pegelow; Winfred Wang; James F Casella; Linda S Resar; Brian Berman; Thomas Adamkiewicz; Lewis L Hsu; Kwaku Ohene-Frempong; Kim Smith-Whitley; Donald Mahoney; J Paul Scott; Gerald M Woods; Masayo Watanabe; Michael R Debaun
Journal:  J Pediatr       Date:  2002-03       Impact factor: 4.406

4.  Challenges of adherence and persistence with iron chelation therapy.

Authors:  John B Porter; Michael Evangeli; Amal El-Beshlawy
Journal:  Int J Hematol       Date:  2011-10-13       Impact factor: 2.490

5.  Iron overload in sickle cell disease.

Authors:  Radha Raghupathy; Deepa Manwani; Jane A Little
Journal:  Adv Hematol       Date:  2010-05-17

6.  Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.

Authors:  Bérengère Koehl; Julie Sommet; Laurent Holvoet; Hendy Abdoul; Priscilla Boizeau; Ghislaine Ithier; Florence Missud; Nathalie Couque; Suzanne Verlhac; Pauline Voultoury; Fatiha Sellami; André Baruchel; Malika Benkerrou
Journal:  Transfusion       Date:  2016-03-28       Impact factor: 3.157

7.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

8.  Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.

Authors:  H C Kim; N P Dugan; J H Silber; M B Martin; E Schwartz; K Ohene-Frempong; A R Cohen
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

9.  Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.

Authors:  Thomas V Adamkiewicz; Miguel R Abboud; Carole Paley; Nancy Olivieri; Melanie Kirby-Allen; Elliott Vichinsky; James F Casella; Ofelia A Alvarez; Julio C Barredo; Margaret T Lee; Rathi V Iyer; Abdullah Kutlar; Kathleen M McKie; Virgil McKie; Nadine Odo; Beatrice Gee; Janet L Kwiatkowski; Gerald M Woods; Thomas Coates; Winfred Wang; Robert J Adams
Journal:  Blood       Date:  2009-08-31       Impact factor: 22.113

10.  Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities.

Authors:  Banu Aygun; Lisa M Wruck; William H Schultz; Brigitta U Mueller; Clark Brown; Lori Luchtman-Jones; Sherron Jackson; Rathi Iyer; Zora R Rogers; Sharada Sarnaik; Alexis A Thompson; Cynthia Gauger; Ronald W Helms; Russell E Ware
Journal:  Am J Hematol       Date:  2012-01-09       Impact factor: 10.047

  10 in total
  1 in total

Review 1.  Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin; Awni Alshurafa; Fateen Ata; Abdulqadir Nashwan
Journal:  Acta Biomed       Date:  2022-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.